Abiomed Inc. (ABMD) Social Stream
ABIOMED INC (ABMD) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ABIOMED INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-01 | 8 | $425 | $269 | $387.333 | $381.02 | 1.66% |
| 2021-12-22 | 7 | $425 | $269 | $379.8 | $381.02 | -0.32% |
| 2022-01-07 | 7 | $425 | $292 | $384.4 | $381.02 | 0.89% |
| 2022-01-24 | 7 | $425 | $292 | $378.4 | $381.02 | -0.69% |
| 2022-02-01 | 6 | $425 | $292 | $372.4 | $381.02 | -2.26% |
| 2022-02-03 | 7 | $425 | $292 | $372.4 | $381.02 | -2.26% |
| 2022-02-04 | 7 | $425 | $275 | $365 | $381.02 | -4.2% |
| 2022-04-11 | 6 | $425 | $275 | $359.166 | $381.02 | -5.74% |
| 2022-05-02 | 7 | $425 | $275 | $359.166 | $381.02 | -5.74% |
| 2022-06-01 | 6 | $425 | $275 | $366 | $381.02 | -3.94% |
| 2022-08-22 | 6 | $425 | $235 | $347 | $381.02 | -8.93% |
| 2022-10-11 | 5 | $355 | $235 | $317.5 | $381.02 | -16.67% |
| 2022-10-27 | 6 | $355 | $235 | $314 | $381.02 | -17.59% |
| 2022-11-01 | 6 | $380 | $235 | $320 | $381.02 | -16.01% |
| 2022-11-03 | 6 | $388 | $300 | $355.6 | $381.02 | -6.67% |
The Trend in the Analyst Price Target
Over the past 30 months, ABMD's average price target has gone up $141.2.
ABMD reports an average of 22.38% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-11 | 6 | 425 | 275 | 359.166 | 299.76 | 19.82% |
| 2022-04-29 | 7 | 425 | 275 | 359.166 | 286.58 | 25.33% |
| 2022-05-02 | 6 | 425 | 275 | 366.000 | 285.71 | 28.1% |
| 2022-10-11 | 5 | 355 | 235 | 317.500 | 243.14 | 30.58% |
| 2022-10-27 | 6 | 355 | 235 | 314.000 | 267.58 | 17.35% |
ABMD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.67 | 1 | 0 | 5 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 31 weeks, ABMD's average broker recommendation rating worsened by 0.67.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ABMD has a greater average analyst price target than 1638.78% of all US stocks.
- In terms of how ABIOMED INC fares relative to Medical Equipment stocks, note that its upside potential (average analyst target price relative to current price) is greater than 71.14% of that group.
- In the context of stocks in the large market cap category, ABIOMED INC's number of analysts covering the stock is higher than 180.13% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, ABIOMED INC's variance in analysts' estimates is lower than -503.25% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to ABIOMED INC are SYK, TFX, and MMM.
View All Top Stocks by Price Target
Is ABMD a Buy, Hold or Sell? See the POWR Ratings now!